Preclinical Atherosclerosis, Global Cardiovascular Risk and Cardiovascular Events

Author(s): S. Novo, G.R. Amoroso, F. Bonura, P. Carità, E. Corrado and G. Novo

DOI: 10.2174/978160805221911201010055

The Treatment of Patients with Preclinical Atherosclerosis

Pp: 55-58 (4)

Buy Chapters
  • * (Excluding Mailing and Handling)

Preclinical Atherosclerosis, Global Cardiovascular Risk and Cardiovascular Events

The Treatment of Patients with Preclinical Atherosclerosis

Author(s): S. Novo, G.R. Amoroso, F. Bonura, P. Carità, E. Corrado and G. Novo

Pp: 55-58 (4)

DOI: 10.2174/978160805221911201010055

* (Excluding Mailing and Handling)

Abstract

Several clinical trials have focused on the effectiveness of antihypertensive drugs on carotid lesions and CV outcome. In the last years, it has also been shown that statins induce a reduction in the progression rate of carotid IMT and the stabilization of the atherosclerotic plaques.


Keywords: Preclinical atherosclerosis, anti-hypertensive therapy, statins, literature evidences.

Related Journals

Related Books